Showing 1 to 1 of 1 results
nbcnews.com
🌐 90% Global Worthiness
Wegovy Shows Promise in Treating Serious Liver Disease
A Novo Nordisk-funded trial shows Wegovy effectively treated MASH in 63% of 800 patients across 37 countries, significantly improving liver inflammation and fibrosis, leading to potential FDA approval by year-end.
Wegovy Shows Promise in Treating Serious Liver Disease
A Novo Nordisk-funded trial shows Wegovy effectively treated MASH in 63% of 800 patients across 37 countries, significantly improving liver inflammation and fibrosis, leading to potential FDA approval by year-end.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results